Notes And Other Explanatory Information [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
|---|---|
| Notes and other explanatory information [abstract] | |
| Disclosure of accounting judgements and estimates [text block] |
1
|
| Disclosure of auditors' remuneration [text block] |
Note 16
|
| Disclosure of authorisation of financial statements [text block] |
Le Conseil d’Administration a arrêté le 6 février 2025 les états financiers consolidés au 31 décembre 2024. Les comptes ne seront définitifs qu’après leur approbation par l’Assemblée Générale des actionnaires qui se tiendra le 29 avril 2025.
|
| Disclosure of basis of preparation of financial statements [text block] |
Note 1
|
| Disclosure of business combinations [text block] |
2
|
| Disclosure of cash and cash equivalents [text block] |
Trésorerie et équivalents de trésorerie
|
| Disclosure of cash flow statement [text block] |
4
|
| Disclosure of changes in accounting policies, accounting estimates and errors [text block] |
Le Groupe n’a pas anticipé de normes et interprétations dont l’application n’est pas obligatoire en 2024.
|
| Disclosure of collateral [text block] |
9.1.10
|
| Disclosure of commitments [text block] |
Note 14
|
| Disclosure of contingent liabilities [text block] |
12
|
| Disclosure of cost of sales [text block] |
Coût des ventes
|
| Disclosure of deferred taxes [text block] |
Principes comptables
|
| Disclosure of depreciation and amortisation expense [text block] |
Les immobilisations corporelles sont amorties selon le mode linéaire, sur les durées d’utilité suivantes :
|
| Disclosure of derivative financial instruments [text block] |
Principes comptables
|
| Disclosure of earnings per share [text block] |
Principes comptables
|
| Disclosure of employee benefits [text block] |
5
|
| Disclosure of entity's operating segments [text block] |
3
|
| Disclosure of events after reporting period [text block] |
Note 17
|
| Disclosure of expenses by nature [text block] |
3.2.1
|
| Disclosure of fair value measurement [text block] |
La juste valeur des actions gratuites correspond à la valeur de l’action au jour de l’attribution sous déduction de l’hypothèse de distribution de dividendes pendant la période d’acquisition.
|
| Disclosure of fair value of financial instruments [text block] |
9.1.9
|
| Disclosure of finance income (cost) [text block] |
Coût de l’endettement financier net
|
| Disclosure of finance income [text block] |
10
|
| Disclosure of financial instruments [text block] |
Note 9
|
| Disclosure of general and administrative expense [text block] |
Frais publi-promotionnels
|
| Disclosure of general information about financial statements [text block] |
er
|
| Disclosure of goodwill [text block] |
7
|
| Disclosure of impairment of assets [text block] |
7
|
| Disclosure of income tax [text block] |
Note 6
|
| Disclosure of information about employees [text block] |
Note 5
|
| Disclosure of information about key management personnel [text block] |
5
|
| Disclosure of intangible assets and goodwill [text block] |
Note 7
|
| Disclosure of inventories [text block] |
Stocks
|
| Disclosure of investments accounted for using equity method [text block] |
Note 8
|
| Disclosure of investments other than investments accounted for using equity method [text block] |
9
|
| Disclosure of issued capital [text block] |
11
|
| Disclosure of liquidity risk [text block] |
11
|
| Disclosure of market risk [text block] |
Afin de gérer son exposition aux risques de change et de taux d’intérêt qui découle de ses opérations courantes, le Groupe utilise des instruments dérivés négociés avec des contreparties de premier plan.
|
| Disclosure of other assets [text block] |
3.3.3
|
| Disclosure of other current liabilities [text block] |
3
|
| Disclosure of other operating income [text block] |
Note 4
|
| Disclosure of other provisions, contingent liabilities and contingent assets [text block] |
Note 12
|
| Disclosure of profit (loss) from operating activities [text block] |
Résultat d’exploitation
|
| Disclosure of property, plant and equipment [text block] |
Immobilisations corporelles
|
| Disclosure of provisions [text block] |
5
|
| Disclosure of research and development expense [text block] |
Frais de recherche et innovation
|
| Disclosure of reserves within equity [text block] |
11
|
| Disclosure of share capital, reserves and other equity interest [text block] |
Note 11
|
| Disclosure of share-based payment arrangements [text block] |
6
|
| Disclosure of subsidiaries [text block] |
1
|
| Disclosure of trade and other receivables [text block] |
Créances clients
|